Subscribe for unlimited access to DynaMed content, CME/CE & MOC credit, and email alerts on content you follow.

Already subscribed? Sign in now

Learn more about CME

Aspirin for Primary Prevention of Cardiovascular Disease

MoreVert
AddCircleOutlineFollow
ShareShare
AddCircleOutlineFollow
Follow
ShareShare
Share
9 Oct 2019

aspirin reported to have 5-year net cardiovascular benefit in about 21% of women and 40% of men ≥ 30 years old without existing cardiovascular disease (CVD) (Ann Intern Med 2019 Sep 17 early online)

1 Jul 2019

American College of Cardiology/American Heart Association (ACC/AHA) recommendations for aspirin use in primary prevention of cardiovascular disease (Circulation 2019 Mar 17)

25 Feb 2019

aspirin may slightly reduce composite risk of cardiovascular events, but may increase risk of bleeding in persons with high cardiovascular risk (JAMA 2019 Jan 22)

25 Feb 2019

aspirin may reduce composite risk of cardiovascular events, but may increase risk of bleeding in persons with low cardiovascular risk (JAMA 2019 Jan 22)

AssignmentLatePRACTICE-CHANGING UPDATE

19 Oct 2018

aspirin 100 mg once daily may not reduce risk of cardiovascular events and may increase risk of gastrointestinal bleeding in adults with moderate risk of cardiovascular disease (Lancet 2018 Sep 22)

28 Sep 2018

aspirin for primary prevention of cardiovascular disease may not reduce risk of all-cause death, dementia, or cardiovascular disease, and may increase risk of major hemorrhage in healthy elderly persons (N Engl J Med 2018 Sep 16 early online)

9 Sep 2018

aspirin may help prevent serious vascular events, but may also increase risk of major bleeding in adults with diabetes without atherosclerotic cardiovascular disease (N Engl J Med 2018 Aug 26 early online)

CheckCircle
Subscribe for unlimited access to DynaMed content.
Already subscribed? Sign in

top